SANCUSO is a prescription medicine used to prevent nausea and vomiting in adults receiving anti-cancer (chemotherapy) treatment that causes moderate or severe vomiting.
SANCUSO is a skin patch (transdermal system) that slowly releases the medicine into your bloodstream while you wear the transdermal system.
It is not known if SANCUSO is safe and effective in children.
Do not use SANCUSO if you are allergic to granisetron or any of the ingredients in SANCUSO. See the end of this page for a list of ingredients in SANCUSO.
have pain or swelling in your stomach area (abdomen).
are pregnant. It is not known if SANCUSO will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
are breastfeeding or plan to breastfeed. It is not known if SANCUSO passes into your breast milk.
Read the Instructions for Use that comes with SANCUSO transdermal system. Use SANCUSO exactly as your healthcare provider tells you to.
A heating pad or heat lamp should not be used where the transdermal system is applied.
You should avoid long periods of exposure to heat because heat can increase the amount of SANCUSO in your blood.
Keep the transdermal system covered with clothing if you will be in direct sunlight or artificial sunlight.
Keep the skin where SANCUSO was applied covered for another 10 days after the transdermal system is taken off to protect from exposure to direct sunlight or artificial sunlight.
agitation
sweating
seeing or hearing things that are not real
flushing (hallucinations)
confusion
high body temperature (hyperthermia)
coma
shaking (tremors), stiff muscles, or muscle twitching
fast heart beat
loss of coordination
changes in blood pressure
seizures
dizziness
nausea, vomiting, diarrhea
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of SANCUSO. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. See full patient information for SANCUSO
SANCUSO® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days.
Sancuso is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the transdermal system.
The most common adverse reaction (≥ 3%) is constipation.
You are encouraged to report suspected adverse reactions to Cumberland Pharmaceuticals Inc. at 1-800-Sancuso or FDA at 1-800-FDA-1088 or www.fda.gov/ medwatch.